IPOs

Epizyme hits the biotech IPO queue with rapid R&D plan for cancer drugs

Epizyme hits the biotech IPO queue with rapid R&D plan for cancer drugs

Fierce Biotech

Enanta: Pharmaceutical Company Treats Shareholders With An IPO

Enanta: Pharmaceutical Company Treats Shareholders With An IPO

Seeking Alpha

Biotech Tetraphase Pharmaceutical sets terms for $75 million IPO

Biotech Tetraphase Pharmaceutical sets terms for $75 million IPO

NASDAQ

Quintiles Confirms 'Go Public' Speculation with IPO and Predicts Rosy Future for CROs

Quintiles Confirms 'Go Public' Speculation with IPO and Predicts Rosy Future for CROs

Outsourcing Pharma

Quintiles talking to banks about an IPO: sources

Quintiles talking to banks about an IPO: sources

Reuters

This Is the Most Exciting IPO of the Year

This Is the Most Exciting IPO of the Year

Motley Fool

Kythera Biopharmaceuticals: Successful Offering Of This One-Drug Company Backed By Bayer

Kythera Biopharmaceuticals: Successful Offering Of This One-Drug Company Backed By Bayer

Seeking Alpha

Intercept Pharma, Kythera Bio jump out of the IPO gate

Intercept Pharma, Kythera Bio jump out of the IPO gate

Fierce Biotech

IPO Preview: Regulus Therapeutics

IPO Preview: Regulus Therapeutics

Seeking Alpha

3 Things to Watch With Pfizer's Zoetis IPO

3 Things to Watch With Pfizer's Zoetis IPO

Motley Fool